• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡罗昔康与β-环糊精包合物的质子核磁共振波谱研究

Proton nuclear magnetic resonance spectroscopy studies of the inclusion complex of piroxicam with beta-cyclodextrin.

作者信息

Fronza G, Mele A, Redenti E, Ventura P

机构信息

CNR-Centro per lo Studio delle Sostanze Organiche Naturali, c/o Chemistry Department, Milano, Italy.

出版信息

J Pharm Sci. 1992 Dec;81(12):1162-5. doi: 10.1002/jps.2600811206.

DOI:10.1002/jps.2600811206
PMID:1491331
Abstract

Proton nuclear magnetic resonance spectroscopy showed that piroxicam sodium salt forms an inclusion complex with beta-cyclodextrin in aqueous solution. The 1:1 stoichiometry of the complex was determined by the continuous variation method. Significant nuclear Overhauser effects were observed between the inner protons of beta-cyclodextrin and protons of both the aromatic rings of piroxicam sodium salt, a result indicating that two isomeric 1:1 complexes must be present in solution within the range of concentrations investigated. The overall association constant was 113 M at 298 K. At concentrations less than 1.0 x 10(-3) M, the complex is completely dissociated.

摘要

质子核磁共振光谱表明,吡罗昔康钠盐在水溶液中与β-环糊精形成包合物。通过连续变化法确定了该配合物的化学计量比为1:1。在β-环糊精的内质子与吡罗昔康钠盐两个芳环的质子之间观察到显著的核Overhauser效应,这一结果表明在所研究的浓度范围内,溶液中必定存在两种异构体1:1配合物。在298K时,总的缔合常数为113M。当浓度小于1.0×10⁻³M时,该配合物完全解离。

相似文献

1
Proton nuclear magnetic resonance spectroscopy studies of the inclusion complex of piroxicam with beta-cyclodextrin.吡罗昔康与β-环糊精包合物的质子核磁共振波谱研究
J Pharm Sci. 1992 Dec;81(12):1162-5. doi: 10.1002/jps.2600811206.
2
Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives.吡罗昔康与β-环糊精衍生物包合作用的研究
Spectrochim Acta A Mol Biomol Spectrosc. 2003 Dec;59(14):3379-86. doi: 10.1016/s1386-1425(03)00164-1.
3
Inclusion of piroxicam into beta-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies.通过超临界二氧化碳将吡罗昔康包合于β-环糊精中:热学、光谱学及物理化学研究
J Pharm Belg. 2000 Jan-Feb;55(1):30-1.
4
The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behaviour. A new specific HPLC method for piroxicam:cyclodextrin formulations.吡罗昔康的pH依赖性分子构象和二聚现象对药物-环糊精复合物化学计量及其色谱行为的影响。一种用于吡罗昔康-环糊精制剂的新型特异性高效液相色谱法。
Eur J Pharm Sci. 2004 Apr;21(5):661-9. doi: 10.1016/j.ejps.2004.01.007.
5
Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.β-环糊精、羟丙基-β-环糊精和三乙酰-β-环糊精在溶液中对盐酸尼卡地平的多模态分子包封。通过¹H NMR和ROESY实验进行结构研究。
Eur J Pharm Sci. 2003 Apr;18(5):285-96. doi: 10.1016/s0928-0987(03)00025-3.
6
Stabilization of an anthrapyrazole antitumour agent, DuP 937, on complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin in aqueous solution.一种蒽吡唑类抗肿瘤药物DuP 937在水溶液中与七(2,6-二-O-甲基)-β-环糊精络合时的稳定性。
J Pharm Biomed Anal. 1994 Oct;12(10):1259-64. doi: 10.1016/0731-7085(94)00063-8.
7
Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.拉曼光谱和固态13C -核磁共振对1:1非晶态吡罗昔康:β-环糊精包合物结构的研究。
Biospectroscopy. 1999;5(4):243-51. doi: 10.1002/(SICI)1520-6343(1999)5:4<243::AID-BSPY5>3.0.CO;2-C.
8
NMR studies of the inclusion complex of cloprostenol sodium salt with beta-cyclodextrin in aqueous solution.氯前列醇钠与β-环糊精在水溶液中包合物的核磁共振研究
Pharm Res. 2008 May;25(5):1142-9. doi: 10.1007/s11095-007-9493-z. Epub 2007 Dec 5.
9
Stereochemistry and dynamics of the inclusion complex of (S)-(+)-fenoprofen with cyclomaltoheptaose (beta-cyclodextrin).(S)-(+)-非诺洛芬与环麦芽七糖(β-环糊精)包合物的立体化学与动力学
Carbohydr Res. 1993 Apr 23;243(1):1-10. doi: 10.1016/0008-6215(93)84077-j.
10
Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion.吡罗昔康与β-环糊精的包合物及其在基于十六烷基三甲基溴化铵的微乳剂中的包封
Int J Pharm. 1999 Jul 20;184(2):157-64. doi: 10.1016/s0378-5173(99)00099-x.

引用本文的文献

1
Integrated computer-aided formulation design: A case study of andrographolide/ cyclodextrin ternary formulation.集成计算机辅助制剂设计:穿心莲内酯/环糊精三元制剂的案例研究
Asian J Pharm Sci. 2021 Jul;16(4):494-507. doi: 10.1016/j.ajps.2021.03.006. Epub 2021 Jun 3.
2
Understanding Surface Interaction and Inclusion Complexes between Piroxicam and Native or Crosslinked β-Cyclodextrins: The Role of Drug Concentration.理解吡罗昔康与天然或交联β-环糊精之间的表面相互作用和包络复合物:药物浓度的作用。
Molecules. 2020 Jun 19;25(12):2848. doi: 10.3390/molecules25122848.
3
Inclusion complexation of phenoxyaliphatic acid derivatives of 3,3'-bis(indolyl)methanes with β-cyclodextrin.
3,3'-双(吲哚基)甲烷的苯氧脂肪族酸衍生物与β-环糊精的包合作用
J Fluoresc. 2014 May;24(3):925-31. doi: 10.1007/s10895-014-1373-4. Epub 2014 Mar 13.
4
Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.吡罗昔康与β-环糊精包合物CHF1194在健康受试者单剂量和稳态条件下的口服生物利用度。
Eur J Clin Pharmacol. 1995;47(6):531-6. doi: 10.1007/BF00193707.